2025-12-29 - Analysis Report
Okay, here's a report based on the data you provided, structured as requested.

**Report on Palantir Technologies Inc. (PLTR)**

**Company Overview:** Palantir Technologies Inc. is a software company that builds data platforms for organizations with complex and sensitive data environments.

**1. Return Rate Comparison (PLTR vs. VOO)**

*   **PLTR Cumulative Return:** 216.33%
*   **VOO Cumulative Return:** 56.58%
*   **Divergence:** 169.9 (Relative Divergence: 80.9)

**Analysis:** Palantir has significantly outperformed the S&P 500 (VOO) during the period examined. The divergence of 169.9 indicates a large difference in cumulative returns. The Relative Divergence of 80.9 suggests that the current performance difference is high relative to its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha    | Beta   | Cap(B) |
|------------|--------|-------|----------|--------|--------|
| 2020-2022  | -54.0% | 81.0% | -38.0%  | -0.0   | 15.3   |
| 2021-2023  | -131.0% | 81.0% | -132.0% | 0.0   | 40.9   |
| 2022-2024  | 155.0% | 81.0% | 134.0%  | 0.0   | 180.3  |
| 2023-2025  | 259.0% | 81.0% | 192.0%  | 0.1   | 449.8  |

**Analysis:** The CAGR, MDD, Alpha, Beta analysis shows a very high level of return in 2023-2025, while the Beta is 0.1 showing very low correlation with the market.

**2. Recent Stock Price Fluctuations**

*   **Current Price:** 188.71
*   **Previous Close:** 194.17
*   **Change:** -2.81
*   **5-day SMA:** 192.87
*   **20-day SMA:** 183.50
*   **60-day SMA:** 181.04

**Analysis:** The current price is below the 5-day SMA, but above the 20-day and 60-day SMAs.  This suggests a recent pullback, but the longer-term trend may still be upward. The price decrease of -2.81 from the previous close indicates a notable negative fluctuation.

**3. Market Risk Indicator, RSI, PPO and Expected Return**

*   **Market Risk Indicator (MRI):** 1.0 (High Investment Recommended)
*   **RSI:** 57.14
*   **PPO:** 0.59
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-04)
*   **Recent (20 days) relative divergence change:** 6.1 (+) (Short-term increase)
*   **Expected Return:** 4.5%

**Analysis:**

*   The MRI of 1.0 suggests a very favorable market environment for investment based on the MRI calculation.
*   The RSI of 57.14 is neutral, indicating neither overbought nor oversold conditions.
*   A positive PPO value suggests that the short-term moving average is above the long-term moving average, indicating a potential upward trend.
*   The hybrid signal suggests to buy 90% of cash
*   The 20-day relative divergence change indicates a short-term upward trend.
*   The expected return of 4.5% is the return when invested long-term (more than 2 years) from this point.

**4. Recent News & Significant Events:**

*   **Sell Recommendation:**  One article suggests analysts believe PLTR may plummet in 2026.
*   **AI Stock Comparison:** PLTR is being compared to other AI stocks (NBIS and CRWV) as a potential investment for 2026.
*   **Analyst Targets & Market Activity:** Several articles discuss fresh forecasts, analyst targets, and market activity related to PLTR, indicating active coverage and debate.
*   **Buy Points:**  One article suggests PLTR is near buy points heading into the final days of 2025.
*   **Positive Developments:** Articles highlight potential positive developments, such as a ShipOS Navy deal and an Nvidia AI partnership.
*   **Friday Slide:** One article mentions a Friday slide in PLTR stock, prompting discussion and analysis.

**Analysis:** The news sentiment appears mixed. There are some concerning articles predicting a significant price drop, but also positive news regarding potential deals, partnerships, and analyst buy recommendations. Investors should be wary of sell recommendations, while weighing the other positive news.

**4-2) Analyst Opinions:**

*   **Consensus:** Hold (Mean: 3.00)
*   **Opinions:** 21
*   **Target Price:** Avg: 186.81 / High: 255.00 / Low: 50.00
*   **Recent Rating Changes:** No changes reported.

**Analysis:** The analyst consensus is "Hold," suggesting a neutral outlook on the stock. The average target price is below the current price, indicating that analysts, on average, do not expect significant upside in the near term. The wide range between the high and low target prices (255 vs 50) reflects significant disagreement among analysts regarding PLTR's future valuation.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출          |
|------------|------|---------------|
| 2025-11-04 | 0.2  | 1.18 B$      |
| 2025-08-05 | 0.14 | 1.00 B$      |
| 2025-05-06 | 0.09 | 0.88 B$      |
| 2024-11-05 | 0.06 | 0.73 B$      |
| 2025-11-04 | 0.06 | 0.73 B$      |

**Analysis:** The table shows a clear trend of increasing EPS and revenue over the recent quarters. This indicates strong growth in Palantir's business performance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-09-30 | $1.18B   | 82.45%        |
| 2025-06-30 | $1.00B   | 80.78%        |
| 2025-03-31 | $0.88B   | 80.43%        |
| 2024-12-31 | $0.83B   | 78.91%        |
| 2024-09-30 | $0.73B   | 79.79%        |

**Analysis:** The revenue is consistently increasing and the profit margin is stable in 80% level. It indicates that the company is growing revenue and keeping profits stable.

**Capital and Profitability:**

| Quarter    | Equity   | ROE    |
|------------|----------|--------|
| 2025-09-30 | $6.59B   | 7.22%  |
| 2025-06-30 | $5.93B   | 5.51%  |
| 2025-03-31 | $5.42B   | 3.95%  |
| 2024-12-31 | $5.00B   | 1.58%  |
| 2024-09-30 | $4.50B   | 3.19%  |

**Analysis:** The equity has been consistently increasing. The ROE has been improving over the most recent quarters, which is a good sign for investors.

**7. Comprehensive Analysis**

Palantir has demonstrated substantial outperformance compared to the S&P 500. Strong revenue and EPS growth, high profit margins, and improving ROE highlight positive financial trends. The high MRI also favors investment. However, investors should note mixed news sentiment, with some analysts predicting a potential price decline. The current analyst consensus is hold, suggesting a neutral outlook on the stock.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.